Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
about
Atypical hemolytic uremic syndromeClinical features of anti-factor H autoantibody-associated hemolytic uremic syndromeHemolytic uremic syndrome: new developments in pathogenesis and treatmentAssociation of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndromeComplement in age-related macular degeneration: a focus on functionAnnexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cellsAlternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous NephropathyCurrent Understanding of the Role of Complement in IgA NephropathyAn imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)Production of biologically active complement factor H in therapeutically useful quantitiesHaemolytic uraemic syndrome.Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndromeThe kidney in thrombotic thrombocytopenic purpura.Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population.Antiphospholipid antibodies: paradigm in transition.Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.Thrombotic microangiopathies: multimers, metalloprotease, and beyond.Genetics and complement in atypical HUS.aHUS caused by complement dysregulation: new therapies on the horizon.Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristicsThrombotic microangiopathy and associated renal disorders.Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndromeSTEC-HUS, atypical HUS and TTP are all diseases of complement activation.Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.Assesment, treatment and prevention of atypical hemolytic uremic syndrome.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.Successful treatment of DEAP-HUS with eculizumab.Cardiovascular complications in atypical haemolytic uraemic syndrome.Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).
P2860
Q21202864-34F79C46-124E-438D-97B4-2E6063558F44Q24606843-93E7AC85-84CA-41E7-940F-CCCCD64C7339Q24613517-1D7B6B14-9443-4E5F-BFCE-4C16917BBF7EQ24634697-3B4A940C-48B2-4504-9B06-7789AA6EC2D4Q24635874-EB31CCE9-8534-4E56-B396-06926B51EE4EQ24646683-C811D480-F0E6-42FC-9BFA-EDD5EA580F59Q26747416-FFB08FE0-9255-4F0A-81B9-398A2A4290D4Q26852163-B6C4D8F6-6175-46EC-BC2F-C2DE86EA7860Q28293350-AE24292F-46BC-4F3B-9530-F8912B592275Q28300280-9A9C50B8-9BD9-46AF-9616-B7F64A58039FQ30244707-91F53604-9248-4ECA-967C-58F30E3497ACQ33377727-CF6B368E-1646-4BE7-A167-5139B3F68525Q33377799-154F01FA-8BA1-451B-A7F6-95F19242C750Q33378236-C1B0D6F8-7906-4A76-9804-4B3A24F3873EQ33378469-F368B5DC-02A8-48B9-BB9A-8D5749E010E4Q33378755-A706C6AA-FDDB-4336-9D06-3B50B2D945D6Q33382404-D1602C7C-EA80-4D04-8EB3-C7A174764F2DQ33382848-1B1076DD-E1E5-44F8-A259-04F66E3B0F6FQ33385035-5D6CE169-F2E3-486D-83C8-D28AE4400D74Q33385154-77EA349B-DCFE-42E3-8B06-25D4C322A224Q33387252-E836D7CF-415D-4EC8-8B6F-C1F8D95225DDQ33389435-FBF1E3B5-70D5-4A9D-82B5-36189693A5FCQ33389945-2BCA2FB9-7D1C-4646-BC54-24845851EA6FQ33390198-E90D5C08-FE09-4352-B601-0145F926AE85Q33393852-9F29DA61-743E-4037-A060-C59F8688687BQ33395682-B4FC0743-F771-4C33-ABEB-3B359B6696FDQ33395774-B3A7198B-0BEB-47B7-A797-7C76A6AA73C0Q33399052-D95B0033-E86E-4DE0-B270-99CFDDF41D60Q33400211-EBB3B3EA-B6DA-49BE-A9E2-2CC265EC1D42Q33402372-0B2D4060-6A8B-443C-9827-D72C09B419EAQ33402827-17AE089D-F869-452F-8DFA-624E896D8ECCQ33403359-3BEFD92C-611B-42EA-9F88-B91271A1EF6EQ33404847-0E64993B-7CCA-4903-9D0C-DD2A9ABA2980Q33405916-EDE8F029-80B2-4FB8-A5A6-71B369FF563FQ33408733-62C13393-C648-4D0E-BF42-3D75D667EB27Q33409198-0AF7F916-4147-40D9-B426-B7060AE933F6Q33411577-434C6E32-D904-40C5-AC97-D36B7CE70E20Q33412640-2B205D47-6C90-4916-8A85-6E33B437FFC1Q33415471-AF17860C-6F5D-4E49-9263-4C411EB82721Q33417246-8A26572B-75F5-44D8-AE5E-041E1E77ED49
P2860
Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Anti factor H autoantibodies b ...... in hemolytic uremic syndrome.
@ast
Anti factor H autoantibodies b ...... in hemolytic uremic syndrome.
@en
type
label
Anti factor H autoantibodies b ...... in hemolytic uremic syndrome.
@ast
Anti factor H autoantibodies b ...... in hemolytic uremic syndrome.
@en
prefLabel
Anti factor H autoantibodies b ...... in hemolytic uremic syndrome.
@ast
Anti factor H autoantibodies b ...... in hemolytic uremic syndrome.
@en
P2093
P1433
P1476
Anti factor H autoantibodies b ...... in hemolytic uremic syndrome.
@en
P2093
Christine Skerka
Hans-Martin Dahse
Martin Oppermann
Peter F Hoyer
Stefanie Strobel
Wei-shih Liu
P304
P356
10.1182/BLOOD-2007-02-071472
P407
P577
2007-05-10T00:00:00Z